ARTICLE | Clinical News
ARC183: Phase I started
August 16, 2004 7:00 AM UTC
Archemix Corp., Boston, Mass. Nuvelo Inc. (NUVO), Sunnyvale, Calif. Product: ARC183 Business: Cardiovascular Molecular target: Thrombin Description: Antithrombin aptamer Indication: Prevent thromboti...